WILLIAMS AND JENSEN, PLLC for ABBOTT LABORATORIES
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Financial Institutions/Investments/Securities FIN
Financial services
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOEL OSWALD | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate tax, including international tax proposals in FY 2012 Administration budget proposal. Tax extenders.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | — |
| KARINA LYNCH | — |
Food Industry (safety, labeling, etc.) FOO
Food and safety. Child nutrition.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER W HATCHER | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Health Issues HCR
Drug safety; Drug importation; authorized generics; drug company settlements; Preserve Access to Affordable Generics Act; Federal preemption for drugs and devices; Medical device safety; Prescription drug advertising; Congressional oversight issues; Deficit Commission; and General health care reform (Patient Protection and Affordable Care Act).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.